• Home
• SCOUT DS®
• Technology
• News & Events
• Company

 

 
• Diabetes: A Global Threat
  
   
• Health Implications of Diabetes
  
   
• Need for Improved Screening
  
   
• A New Approach to Screening
 
• No Blood, Fasting, or Waiting
  
   
• Clinical Performance
  
   
• Interpretation of Results
  
   
• SCOUT DS - Video
  

A New Approach to Diabetes Screening

The SCOUT DS® is the first noninvasive test that can replace conventional blood-based diabetes screening. The easy to operate SCOUT DS device needs no blood and does not require fasting. The patient simply places a forearm on the portable table-top unit, and a quantitative result is reported in under four minutes.

SCOUT DS is Indicated for Use for the noninvasive screening of individuals 18 years or older who are at risk for prediabetes and/or type 2 diabetes to determine whether diagnostic testing is necessary. Prediabetes is defined as impaired glucose tolerance.

Easy Test Procedure

1: Enter patient age and gender.

2: Place arm in cradle.

3: Result in under 4 minutes.

Source:

• D.R. McCance et al., J Clin Invest 91:2470-2478 (1993)

SCOUT DS has received approval from Health Canada for commercial distribution and it has been granted a CE Mark in the European Union.

US Caution: Federal law restricts the SCOUT DS system to investigational use only. Commercial distribution has not been granted by the US FDA. See SCOUT DS Operation Manual for descriptions of all relevant Warnings, Cautions, Contraindications, & Safety Information.